-
Something wrong with this record ?
GPR160 is not a receptor of anorexigenic cocaine- and amphetamine-regulated transcript peptide
LC. Freitas-Lima, A. Pačesová, J. Staňurová, P. Šácha, A. Marek, M. Hubálek, J. Kuneš, B. Železná, L. Maletínská
Language English Country Netherlands
Document type Journal Article
- MeSH
- Cocaine * MeSH
- Rats MeSH
- Ligands MeSH
- Nerve Tissue Proteins * genetics metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Cocaine- and amphetamine-regulated transcript peptide (CARTp) is an anorexigenic neuropeptide whose receptor is undisclosed. Previously, we reported the specific binding of CART(61-102) to pheochromocytoma PC12 cells, where CART(61-102) affinity and the number of binding sites per cell corresponded to ligand-receptor binding. Recently, Yosten et al. designated orphan GPR160 as the CARTp receptor, because the GPR160 antibody abolished neuropathic pain and anorexigenic effects induced by CART(55-102) and exogenous CART(55-102) coimmunoprecipitated with GPR160 in KATOIII cells. As no direct evidence that CARTp is a ligand for GPR160 has been described, we decided to verify this hypothesis by testing CARTp affinity to the GPR160 receptor. We investigated the GPR160 expression in PC12 cells since it is cell line known to specifically bind CARTp. Moreover, we examined the specific CARTp binding in THP1 cells, with high endogenous GPR160 expression and GPR160-transfected cell lines U2OS and U-251 MG. In PC12 cells, the GPR160 antibody did not compete for specific binding with 125I-CART(61-102) or with 125I-CART(55-102), and GPR160 mRNA expression and GPR160 immunoreactivity were not detected. Moreover, THP1 cells did not show any 125I-CART(61-102) or 125I-CART(55-102) specific binding despite GPR160 detection by fluorescent immunocytochemistry (ICC). Finally, no 125I-CART(61-102) or 125I-CART(55-102) specific binding in the GPR160-transfected cell lines U2OS and U-251 MG, selected due to their negligible endogenous expression of GPR160, was detected, despite the detection of GPR160 by fluorescent ICC. Our binding studies clearly demonstrated that GPR160 cannot be a receptor for CARTp. Further studies are needed to identify true CARTp receptors.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011040
- 003
- CZ-PrNML
- 005
- 20230801132756.0
- 007
- ta
- 008
- 230718s2023 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejphar.2023.175713 $2 doi
- 035 __
- $a (PubMed)37054941
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Freitas-Lima, Leandro Ceotto $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic
- 245 10
- $a GPR160 is not a receptor of anorexigenic cocaine- and amphetamine-regulated transcript peptide / $c LC. Freitas-Lima, A. Pačesová, J. Staňurová, P. Šácha, A. Marek, M. Hubálek, J. Kuneš, B. Železná, L. Maletínská
- 520 9_
- $a Cocaine- and amphetamine-regulated transcript peptide (CARTp) is an anorexigenic neuropeptide whose receptor is undisclosed. Previously, we reported the specific binding of CART(61-102) to pheochromocytoma PC12 cells, where CART(61-102) affinity and the number of binding sites per cell corresponded to ligand-receptor binding. Recently, Yosten et al. designated orphan GPR160 as the CARTp receptor, because the GPR160 antibody abolished neuropathic pain and anorexigenic effects induced by CART(55-102) and exogenous CART(55-102) coimmunoprecipitated with GPR160 in KATOIII cells. As no direct evidence that CARTp is a ligand for GPR160 has been described, we decided to verify this hypothesis by testing CARTp affinity to the GPR160 receptor. We investigated the GPR160 expression in PC12 cells since it is cell line known to specifically bind CARTp. Moreover, we examined the specific CARTp binding in THP1 cells, with high endogenous GPR160 expression and GPR160-transfected cell lines U2OS and U-251 MG. In PC12 cells, the GPR160 antibody did not compete for specific binding with 125I-CART(61-102) or with 125I-CART(55-102), and GPR160 mRNA expression and GPR160 immunoreactivity were not detected. Moreover, THP1 cells did not show any 125I-CART(61-102) or 125I-CART(55-102) specific binding despite GPR160 detection by fluorescent immunocytochemistry (ICC). Finally, no 125I-CART(61-102) or 125I-CART(55-102) specific binding in the GPR160-transfected cell lines U2OS and U-251 MG, selected due to their negligible endogenous expression of GPR160, was detected, despite the detection of GPR160 by fluorescent ICC. Our binding studies clearly demonstrated that GPR160 cannot be a receptor for CARTp. Further studies are needed to identify true CARTp receptors.
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ligandy $7 D008024
- 650 12
- $a proteiny nervové tkáně $x genetika $x metabolismus $7 D009419
- 650 12
- $a kokain $7 D003042
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pačesová, Andrea $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic
- 700 1_
- $a Staňurová, Jana $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic
- 700 1_
- $a Šácha, Pavel $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic
- 700 1_
- $a Marek, Aleš $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic
- 700 1_
- $a Hubálek, Martin $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic
- 700 1_
- $a Kuneš, Jaroslav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic; Institute of Physiology of the Czech Academy of Sciences, Vídeňská 1083, 142 00, Prague, Czech Republic
- 700 1_
- $a Železná, Blanka $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic
- 700 1_
- $a Maletínská, Lenka $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic. Electronic address: lenka.maletinska@uochb.cas.cz
- 773 0_
- $w MED00001641 $t European journal of pharmacology $x 1879-0712 $g Roč. 949, č. - (2023), s. 175713
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37054941 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132753 $b ABA008
- 999 __
- $a ok $b bmc $g 1963447 $s 1197305
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 949 $c - $d 175713 $e 20230411 $i 1879-0712 $m European journal of pharmacology $n Eur J Pharmacol $x MED00001641
- LZP __
- $a Pubmed-20230718